Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose R207910 in treatment-naive pulmonary tuberculosis
2004-002202-30Phase 2Completed
- Sponsor
- Tibotec
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bedaquiline in Tuberculosis (TB), sponsored by Tibotec. Primary endpoint: Effect on Mycobacterium tuberculosis sputum viable count. Started Feb 2005; status: completed.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on 2004-002202-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002202-30.